Advertisement

India's Rs 10,000 crore biopharma shakti scheme, cancer drug relief and more

Despite health allocations crossing Rs 1 lakh crore, nearly half of Indians still avoid government healthcare facilities—a paradox highlighted by veteran health editor Sneha Mordani on Health360. She pointed to public distrust driven by staff shortages and uneven quality of care. The programme examined the Rs 10,000 crore Biopharma Shakti scheme, aimed at transforming India from a generics powerhouse into a global pharma innovation hub. It also noted the exemption of 17 essential cancer drugs from customs duty, reducing treatment costs. The show featured an AIIMS Delhi study using speech analysis to detect depression with 75% accuracy and warned about cancer-linked "forever chemicals" in common household products.

Read More

VIDEOS FROM OTHER SECTIONS

LATEST VIDEOS

Video: Terrifying moment when 'tsunami' swing snaps mid-air, crashes to ground in Surajkund mela

A horrifying incident took place at the annual Surajkund Mela in Faridabad when a joyride collapsed there on Saturday. According to officials, a policeman died from injuries he sustained while trying to rescue people as the tragedy unfolded. They added that 12 other people were injured. The incident took place when a 'tsunami' swing snapped mid-air and came crashing on to the ground. Police Inspector Jagdish Prasad tried to save people when the joyride began tilting but suffered fatal injuries, officials said, according to news agency ANI. He was declared brought dead at the hospital.

advertisement

Jewellery, pharma, smartphones to be tariff-free: Piyush Goyal details US deal

Union Minister Piyush Goyal details the landmark bilateral trade agreement between India and the United States. Highlighting the vision of Prime Minister Narendra Modi and President Donald Trump, Goyal announced that reciprocal tariffs on Indian exports to the US will drop from 50% to 18%, making India more competitive than China, Vietnam, and Bangladesh.